APA (7th ed.) Citation

A, G., G, P., N, Z., E, M., A, H., P, M., . . . GM, S. (2026). Pharmacological profiling of intravenous MP-04: Sustained NAD+ augmentation, immune modulation, and renal protection in preclinical models. Frontiers in pharmacology, 17, 1832979. https://doi.org/10.3389/fphar.2026.1832979

Chicago Style (17th ed.) Citation

A, Ghosh, et al. "Pharmacological Profiling of Intravenous MP-04: Sustained NAD+ Augmentation, Immune Modulation, and Renal Protection in Preclinical Models." Frontiers in Pharmacology 17 (2026): 1832979. https://doi.org/10.3389/fphar.2026.1832979.

MLA (9th ed.) Citation

A, Ghosh, et al. "Pharmacological Profiling of Intravenous MP-04: Sustained NAD+ Augmentation, Immune Modulation, and Renal Protection in Preclinical Models." Frontiers in Pharmacology, vol. 17, 2026, p. 1832979, https://doi.org/10.3389/fphar.2026.1832979.